Abstract
The present invention relates to methods for treating inflammatory bowel disease (IBD). Particularly, the present invention relates to use of specific inhibitors of Voltage-Dependent Anion Channel (VDAC1), such as piperazine- and/or piperidine-derivatives, among others, e.g., peptides and oligonucleotides, for treating IBD.
| Original language | English |
|---|---|
| Patent number | WO2020110112 |
| IPC | A61P 29/ 00 A I |
| Priority date | 26/11/18 |
| State | Published - 4 Jun 2020 |